AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Insulin Human EP
10 registrations across 1 African market— 10 active
Markets with Insulin Human EP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ACTRAPID Suspension for injection | 🇹🇿Tanzania | Novo Nordisk A/S | active | — |
| Wosulin 30/70 Suspension for injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| HUMODAR B 100R Suspension for injection | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| Biosulin 30:70 Injection | 🇹🇿Tanzania | M.J Biopharm Private Limuted | active | — |
| Wosulin N Suspension for injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| Insugen - 30/70 Cartridge Injection | 🇹🇿Tanzania | Biocon Biologics Limited | active | — |
| Wosulin R Suspension for injection | 🇹🇿Tanzania | Wockhardt Limited | active | — |
| Insugen 30/70 Injection | 🇹🇿Tanzania | Biocon Biologics Limited | active | — |
| Insugen N Injection | 🇹🇿Tanzania | Biocon Biologics Limited | active | — |
| Insugen R Injection | 🇹🇿Tanzania | Biocon Biologics Limited | active | — |
Insulin Human EP in Africa — Regulatory Overview
Insulin Human EP is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.